Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center

Leukemia. 2014 Jun;28(6):1365-8. doi: 10.1038/leu.2014.42. Epub 2014 Jan 23.

¹ 1] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA [2] Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
² Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
³ Division of Hematopathology, Department of Pathology, The Ohio State University, Columbus, OH, USA.
⁴ 1] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA [2] Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA [3] Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
⁵ 1] Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA [2] Division of Cytogenetics, Department of Pathology, The Ohio State University, Columbus, OH, USA.

No abstract available

Publication types